Cellectar Biosciences Inc

NASDAQ:CLRB  
1.29
+0.04 (+3.20%)
Products

Cellectar Biosciences Says Granted Japanese Composition Of Matter Patent For Its Phospholipid-Ether Drug Conjugates

Published: 03/09/2021 15:17 GMT
Cellectar Biosciences Inc (CLRB) - Cellectar Biosciences - Granted Japanese Composition of Matter Patent for Its Phospholipid-ether Drug Conjugates.